Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
Merck Sharp & Dohme LLC
Silvia Novello; Dariusz M Kowalski; Alexander Luft; Mahmut Gümüş; David Vicente; Julien Mazières; Jeronimo Rodríguez-Cid; Ali Tafreshi; Ying Cheng; Ki Hyeong Lee; Alexander Golf; Shunichi Sugawara; Andrew G Robinson; Balazs Halmos; Erin Jensen; Paul Schwarzenberger; M Catherine Pietanza; Luis Paz-Ares
Biostatistics and Research Decision Sciences, Merck & Co, Inc, Rahway, NJ.